TP53 and age-related macular degeneration: Our findings demonstrate that DUSP4 expression is upregulated in both clinical AMD specimens and SI-induced experimental models, where it mitigates RPE senescence through coordinated inhibition of p38, p53, and NF-κB signaling pathways.